Development and Evaluation of Antibody Proteomics Technology for Rapid and Comprehensive Identification of Potential Biomarkers and Therapeutic Targets-Reference-Cited by-同舟云学术

Development and Evaluation of Antibody Proteomics Technology for Rapid and Comprehensive Identification of Potential Biomarkers and Therapeutic Targets

Published:2018-05-01 Issue:5 Volume:41 Page:663-669
ISSN:0918-6158
Container-title:Biological and Pharmaceutical Bulletin
language:en
Short-container-title:Biol. Pharm. Bull.

Author:

Nagano Kazuya¹

Affiliation:

1. Laboratory of Toxicology and Safety Science, Graduate School of Pharmaceutical Sciences, Osaka University

Publisher

Pharmaceutical Society of Japan

Subject

Pharmaceutical Science,Pharmacology,General Medicine

Link

https://www.jstage.jst.go.jp/article/bpb/41/5/41_b17-01041/_pdf

Reference30 articles.

1. 1) Evans WE, Relling MV. Moving towards individualized medicine with pharmacogenomics. Nature, 429, 464–468 (2004).

2. 2) Plenge RM, Scolnick EM, Altshuler D. Validating therapeutic targets through human genetics. Nat. Rev. Drug Discov., 12, 581–594 (2013).

3. 3) Hanash S. Disease proteomics. Nature, 422, 226–232 (2003).

4. 4) Kavallaris M, Marshall GM. Proteomics and disease: opportunities and challenges. Med. J. Aust., 182, 575–579 (2005).

5. 5) Kaufmann H, Bailey JE, Fussenegger M. Use of antibodies for detection of phosphorylated proteins separated by two-dimensional gel electrophoresis. Proteomics, 1, 194–199 (2001).

Cited by 6 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. CALU promotes lung adenocarcinoma progression by enhancing cell proliferation, migration and invasion;Respiratory Research;2024-07-05

2. A Network Analysis of Molecular Interactions to Study the Development of New-onset Diabetes and Hypertension after COVID-19 Infection Using Bioinformatics Tools;2023-09-11

3. Crosstalk between the peripheral nervous system and breast cancer influences tumor progression;Biochimica et Biophysica Acta (BBA) - Reviews on Cancer;2022-11

4. New immunological markers for the identification of lung cancer risk groups among workers in hazardous industries in Kuzbass region;Journal of Physics: Conference Series;2021-01-01

5. Evaluation of Matrix Metalloproteinase 9 Serum Concentration as a Biomarker in Malignant Mesothelioma;Disease Markers;2019-05-02